Intensive Blood Pressure Control After Stroke Cuts Cardiovascular Risk by 21%, Trial Finds
Found this article helpful?
Share it with your network and spread the knowledge!

Stroke survivors who received intensive blood pressure treatment targeting a systolic blood pressure below 120 mm Hg were significantly less likely to die or suffer major cardiovascular events than those treated to the standard target of below 140 mm Hg, according to late-breaking research presented at the American Heart Association's Scientific Sessions 2026 in Chicago. The OPTIMAL-Stroke trial, conducted at 30 health centers in Brazil with 4,368 participants, found that over four years, intensive therapy reduced the risk of major cardiovascular events by about 21% compared to standard treatment. Cardiovascular events occurred in 10.9% of the intensive group versus 13.5% of the standard group, and recurrent strokes were lower in the intensive group at 4.7% versus 6.4%. The findings were simultaneously published in the New England Journal of Medicine.
High blood pressure is the single most important modifiable risk factor for stroke, and controlling it is essential to prevent a second stroke. Nearly 185,000 recurrent strokes occur in the U.S. each year, and most can be avoided through lifestyle changes and risk factor control, according to the 2021 American Heart Association/American Stroke Association Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. The trial enrolled adults who had previously experienced an ischemic stroke or transient ischemic attack (TIA) and had elevated blood pressure between 130 and 180 mm Hg.
"Controlling blood pressure after a stroke is especially important because it can help prevent another stroke, prevent other cardiovascular complications and protect patients' lives," said Otavio Berwanger, M.D., Ph.D., chair of the OPTIMAL study Steering Committee and executive director at The George Institute for Global Health. The American Heart Association/American College of Cardiology Joint 2025 Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults recommends maintaining systolic blood pressure under 130 mm Hg and encourages measures less than 120 mm Hg for people at increased cardiovascular risk. The trial's results support these more aggressive targets for secondary prevention.
Researchers noted that serious adverse events were similar in both groups, but an increase in kidney-related events in the intensive group highlights the need for individualized treatment and careful monitoring of kidney function. "A lower blood pressure target may offer greater protection, and we must ensure that the right target is achieved safely and tailored to each patient," said principal investigator Gisele Sampaio, M.D., Ph.D., professor of neurology at the Federal University of São Paulo. For Texas, where cardiovascular disease remains a leading cause of death, these findings could inform clinical practice and public health strategies, potentially reducing the burden of recurrent strokes on the state's healthcare system and economy. The trial's limitations include that not all participants achieved the intensive target and results may not be fully generalizable outside Brazil.
The American Heart Association provides resources for stroke survivors, including Preventing Another Stroke and Understanding Blood Pressure Readings. The study was presented at Scientific Sessions 2026, and the abstract is available in the 2026 Online Program Planner. For more information, visit heart.org or stroke.org.
